Related Experiment Video
Updated: Apr 19, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
MicroRNAs in Human Pituitary Adenomas
Xu-Hui Li1, Elaine Lu Wang2, Hai-Meng Zhou3
1Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing 100084, China ; Zhejiang Provincial Key Laboratory of Applied Enzymology, Yangtze Delta Region Institute of Tsinghua University, Jiaxing, Zhejiang 314006, China.
Abstract:
MicroRNAs (miRNAs) are a class of recently identified noncoding RNAs that regulate gene expression at posttranscriptional level. Due to the large number of genes regulated by miRNAs, miRNAs play important roles in many cellular processes. Emerging evidence indicates that miRNAs are dysregulated in pituitary adenomas, a class of intracranial neoplasms which account for 10-15% of diagnosed brain tumors. Deregulated miRNAs and their targets contribute to pituitary adenomas progression and are associated with cell cycle control, apoptosis, invasion, and pharmacological treatment of pituitary adenomas. To provide an overview of miRNAs dysregulation and functions of these miRNAs in pituitary adenoma progression, we summarize the deregulated miRNAs and their targets to shed more light on their potential as therapeutic targets and novel biomarkers.
Insights
MicroRNAs (miRNAs) are key regulators of gene expression. Dysregulated miRNAs are implicated in pituitary adenoma progression, offering potential as therapeutic targets and biomarkers.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are noncoding RNAs regulating gene expression posttranscriptionally.
- Pituitary adenomas are intracranial neoplasms with significant prevalence.
- Emerging evidence links miRNA dysregulation to pituitary adenoma development and progression.
Purpose of the Study:
- To review the dysregulated microRNAs in pituitary adenomas.
- To elucidate the functions of these microRNAs in tumor progression.
- To highlight their potential as therapeutic targets and biomarkers.
Main Methods:
- Literature review of studies on microRNAs in pituitary adenomas.
- Analysis of deregulated miRNAs and their gene targets.
- Synthesis of information on miRNA involvement in cellular processes relevant to pituitary adenomas.
Main Results:
- Identified specific microRNAs that are dysregulated in pituitary adenomas.
- Linked these deregulated miRNAs to key cellular processes including cell cycle control, apoptosis, and invasion.
- Associated miRNA targets with pituitary adenoma progression and treatment response.
Conclusions:
- MicroRNA dysregulation is a significant factor in pituitary adenoma progression.
- Targeting specific microRNAs may offer novel therapeutic strategies.
- Dysregulated microRNAs show promise as diagnostic and prognostic biomarkers for pituitary adenomas.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs

